Safety of Simvastatin and Goal Attainment for Low-Density Lipoprotein Cholesterol in Sultan Qaboos University Hospital
Objectives: Despite the scientific evidence of reducing cardiac events with HMG Co-A reductase inhibitors (statins) therapy in both primary and secondary preventions, these therapies continue to be underutilized in patients receiving convictional care. Simvastatin, a HMG Co-A inhibitor agent, is the...
Shranjeno v:
| Principais autores: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oman Medical Specialty Board
2010-10-01
|
| Serija: | Oman Medical Journal |
| Teme: | |
| Online dostop: | http://www.omjournal.org/fultext_PDF.aspx?DetailsID=17&type=fultext |
| Oznake: |
Brez oznak, prvi označite!
|